BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 17893685)

  • 1. Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM.
    La Canna G; Airoldi F; Capritti E; Grimaldi A; Colombo A; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):570-6. PubMed ID: 17893685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: clinicopathological correlations.
    Arrazaghi AA; Butany JW; Williams WG; Wigle DE; Rakowski H
    Can J Cardiol; 2001 Feb; 17(2):197-202. PubMed ID: 11223490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
    Firoozi S; Elliott PM; Sharma S; Murday A; Brecker SJ; Hamid MS; Sachdev B; Thaman R; McKenna WJ
    Eur Heart J; 2002 Oct; 23(20):1617-24. PubMed ID: 12323162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myectomy for hypertrophic obstructive cardiomyopathy.
    McRae ME
    Can J Cardiovasc Nurs; 2007; 17(2):22-30. PubMed ID: 17583317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
    Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term outcome of a patient with hypertrophic obstructive cardiomyopathy treated by alcohol septal transcoronary ablation].
    Pillière R; Gerardin B; Petitier H; Hue S; Raymond P; N'Guyen A; Dubourg O
    Arch Mal Coeur Vaiss; 2002 Mar; 95(3):213-7. PubMed ID: 11998337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines.
    Maron BJ
    Prog Cardiovasc Dis; 2012; 54(6):523-8. PubMed ID: 22687595
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term effects of varying alcohol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy: a randomized study with a follow-up up to 11 years.
    Veselka J; Tomašov P; Zemánek D
    Can J Cardiol; 2011; 27(6):763-7. PubMed ID: 22000583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast echocardiography guidance for alcohol septal ablation of hypertrophic obstructive cardiomyopathy.
    Himbert D; Brochet E; Ducrocq G; Vahanian A
    Eur Heart J; 2010 May; 31(9):1148. PubMed ID: 20019022
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern.
    Coakley E; Steinberg DH; Tibrewala A; Asch F; Pichard AD; Kent KM; Lindsay J
    Am J Cardiol; 2008 Sep; 102(5):621-4. PubMed ID: 18721524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-surgical myocardial ablation: for hypertrophic obstructive cardiomyopathy.
    Sigwart U
    Cardiologia; 1998 Feb; 43(2):157-61. PubMed ID: 9557371
    [No Abstract]   [Full Text] [Related]  

  • 18. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
    Woo A; Rakowski H
    Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach to septal ablation: glue (cyanoacrylate) septal ablation.
    Oto A; Aytemir K; Deniz A
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1021-5. PubMed ID: 17525960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: novel application of the cutting balloon.
    Polin N; Feldman D; Naidu SS
    J Invasive Cardiol; 2006 Sep; 18(9):436-7. PubMed ID: 16954586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.